VERV

Verve Therapeutics

Delisted

VERV was delisted on the 24th of July, 2025.

5 hedge funds and large institutions have $1.13M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 166 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 166

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1 -$137M
2 -$82.6M
3 -$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M